Patents Assigned to Deuteria Pharmaceuticals, Inc.
  • Deuterium-enriched lenalidomide
    Patent number: 9023868
    Abstract: The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: May 5, 2015
    Assignee: Deuteria Pharmaceuticals, Inc.
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED LENALIDOMIDE
    Publication number: 20140142141
    Abstract: The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: January 24, 2014
    Publication date: May 22, 2014
    Applicant: DEUTERIA PHARMACEUTICALS, INC.
    Inventor: Anthony W. CZARNIK
  • Deuterium-enriched lenalidomide
    Patent number: 8669276
    Abstract: The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: September 9, 2012
    Date of Patent: March 11, 2014
    Assignee: Deuteria Pharmaceuticals, Inc.
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED LENALIDOMIDE
    Publication number: 20130245067
    Abstract: The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 9, 2012
    Publication date: September 19, 2013
    Applicant: DEUTERIA PHARMACEUTICALS, INC.
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED DONEPEZIL
    Publication number: 20130090357
    Abstract: The present application describes deuterium-enriched donepezil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: October 3, 2012
    Publication date: April 11, 2013
    Applicant: DEUTERIA PHARMACEUTICALS INC
    Inventor: DEUTERIA PHARMACEUTICALS INC.
  • Deuterium-enriched donepezil
    Patent number: 8304435
    Abstract: The present application describes deuterium-enriched donepezil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: November 6, 2012
    Assignee: Deuteria Pharmaceuticals Inc.
    Inventor: Anthony W Czarnik
  • Deuterium-enriched lenalidomide
    Patent number: 8288414
    Abstract: The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: October 16, 2012
    Assignee: Deuteria Pharmaceuticals, Inc.
    Inventor: Anthony W. Czarnik
  • 2,6-DIOXO-3-DEUTERO-PIPERDIN-3-YL-ISOINDOLINE COMPOUNDS
    Publication number: 20120252844
    Abstract: The present application describes 2-(2?,6?-dioxo-3?-deutero-piperidin-3?-yl)isoindoles, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: March 28, 2012
    Publication date: October 4, 2012
    Applicant: DEUTERIA PHARMACEUTICALS, INC.
    Inventor: Sheila DeWitt